05
Pharmacological management of diabetes in severe mental illness: A comprehensive clinical review of efficacy, safety and tolerability
05
Apr
There is increasing evidence that people with severe mental illness (SMI) have considerably worse physical health than the general population. A recent study published in the Expert Review of Clinical Pharmacology summarises the published efficacy and tolerability of pharmacotherapeutic interventions in type 2 diabetes mellitus (T2DM) in severe mental illness (SMI), focusing on glucose lowering therapies. In […]